HEADER PHOTOSYNTHESIS 23-SEP-22 8EL3 TITLE LIGHT HARVESTING PHYCOBILIPROTEIN HAPE555 FROM THE CRYPTOPHYTE TITLE 2 HEMISELMIS ANDERSENII CCMP644 IN A LOOSE INTERFACE FILAMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHYCOERYTHRIN ALPHA-1 SUBUNIT; COMPND 3 CHAIN: A, G, J, K; COMPND 4 SYNONYM: PHYCOERYTHRIN PE555 ALPHA-1 SUBUNIT,PE555A-1; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: PHYCOERYTHRIN550 BETA SUBUNIT; COMPND 7 CHAIN: B, D, F, H; COMPND 8 MOL_ID: 3; COMPND 9 MOLECULE: PHYCOERYTHRIN ALPHA-2 SUBUNIT; COMPND 10 CHAIN: C, E, I, L; COMPND 11 SYNONYM: PHYCOERYTHRIN PE555 ALPHA-2 SUBUNIT,PE555A-2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 3 ORGANISM_TAXID: 464988; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 6 ORGANISM_TAXID: 464988; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HEMISELMIS ANDERSENII; SOURCE 9 ORGANISM_TAXID: 464988 KEYWDS PHYCOBILIPROTEIN, ANTENNA, LIGHT HARVESTING, CRYPTOPHYTE, ALGAE, KEYWDS 2 GLOBIN, CALM, CARSP, PHOTOSYNTHESIS, PHYCOERYTHRIN, HEMISELMIS EXPDTA X-RAY DIFFRACTION AUTHOR H.W.RATHBONE,K.A.MICHIE,A.L.LAOS,P.M.G.CURMI REVDAT 3 29-NOV-23 8EL3 1 JRNL REVDAT 2 15-NOV-23 8EL3 1 JRNL REVDAT 1 25-OCT-23 8EL3 0 JRNL AUTH H.W.RATHBONE,A.J.LAOS,K.A.MICHIE,H.IRANMANESH,J.BIAZIK, JRNL AUTH 2 S.C.GOODCHILD,P.THORDARSON,B.R.GREEN,P.M.G.CURMI JRNL TITL MOLECULAR DISSECTION OF THE SOLUBLE PHOTOSYNTHETIC ANTENNA JRNL TITL 2 FROM THE CRYPTOPHYTE ALGA HEMISELMIS ANDERSENII. JRNL REF COMMUN BIOL V. 6 1158 2023 JRNL REFN ESSN 2399-3642 JRNL PMID 37957226 JRNL DOI 10.1038/S42003-023-05508-4 REMARK 2 REMARK 2 RESOLUTION. 1.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 129618 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.530 REMARK 3 FREE R VALUE TEST SET COUNT : 1989 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.3300 - 3.7800 1.00 9472 145 0.1590 0.1883 REMARK 3 2 3.7800 - 3.0000 1.00 9379 147 0.1529 0.1757 REMARK 3 3 3.0000 - 2.6200 1.00 9317 145 0.1587 0.1954 REMARK 3 4 2.6200 - 2.3800 1.00 9283 143 0.1522 0.1857 REMARK 3 5 2.3800 - 2.2100 1.00 9309 143 0.1512 0.1913 REMARK 3 6 2.2100 - 2.0800 1.00 9283 143 0.1524 0.1863 REMARK 3 7 2.0800 - 1.9800 1.00 9247 155 0.1853 0.2059 REMARK 3 8 1.9800 - 1.8900 1.00 9275 140 0.1794 0.2143 REMARK 3 9 1.8900 - 1.8200 1.00 9280 146 0.1795 0.2267 REMARK 3 10 1.8200 - 1.7600 1.00 9188 140 0.1977 0.2212 REMARK 3 11 1.7600 - 1.7000 0.99 9212 147 0.2148 0.2712 REMARK 3 12 1.7000 - 1.6500 0.98 9098 137 0.2494 0.2696 REMARK 3 13 1.6500 - 1.6100 0.93 8683 136 0.2976 0.2998 REMARK 3 14 1.6100 - 1.5700 0.82 7603 122 0.3444 0.3782 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.213 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.813 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.58 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.013 10016 REMARK 3 ANGLE : 1.385 13610 REMARK 3 CHIRALITY : 0.062 1462 REMARK 3 PLANARITY : 0.009 1732 REMARK 3 DIHEDRAL : 16.269 3646 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8EL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1000268626. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 129756 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.570 REMARK 200 RESOLUTION RANGE LOW (A) : 48.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.39900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.14 REMARK 200 STARTING MODEL: 4LMX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350 25% (W/V) + NABR 0.01M, 150NL REMARK 280 MOTHER + 150 NL PROTEIN STOCK, CRYOPROTECTANT OF 20% GLYCEROL, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.42000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H, K, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 65 REMARK 465 SER A 66 REMARK 465 VAL A 67 REMARK 465 MET D 1 REMARK 465 LEU D 2 REMARK 465 ASP D 3 REMARK 465 ALA D 4 REMARK 465 MET F 1 REMARK 465 LEU F 2 REMARK 465 ASP F 3 REMARK 465 ALA F 4 REMARK 465 LYS G 65 REMARK 465 SER G 66 REMARK 465 VAL G 67 REMARK 465 MET H 1 REMARK 465 LEU H 2 REMARK 465 ASP H 3 REMARK 465 ALA H 4 REMARK 465 LYS J 65 REMARK 465 SER J 66 REMARK 465 VAL J 67 REMARK 465 LYS K 65 REMARK 465 SER K 66 REMARK 465 VAL K 67 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HE22 GLN F 148 O HOH F 301 1.33 REMARK 500 HE22 GLN H 148 O HOH F 301 1.54 REMARK 500 O HOH C 239 O HOH C 240 2.13 REMARK 500 NE2 GLN F 148 O HOH F 301 2.16 REMARK 500 O HOH C 207 O HOH D 370 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH F 394 O HOH G 242 2557 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 28 -167.51 -127.00 REMARK 500 THR B 75 148.72 79.97 REMARK 500 THR D 75 149.96 78.91 REMARK 500 ASN F 70 -0.94 73.62 REMARK 500 THR F 75 146.33 79.77 REMARK 500 THR H 75 142.90 81.47 REMARK 500 ALA I 28 -167.51 -127.00 REMARK 500 REMARK 500 REMARK: NULL DBREF 8EL3 A 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL3 B 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL3 C 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL3 D 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL3 E 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL3 F 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL3 G 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL3 H 1 177 UNP U5T8W0 U5T8W0_HEMAN 1 177 DBREF 8EL3 I 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 DBREF 8EL3 J 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL3 K 1 67 UNP U5TBU5 PHEA1_HEMAN 48 114 DBREF 8EL3 L 1 62 UNP U5TBJ3 PHEA2_HEMAN 48 109 SEQADV 8EL3 VAL B 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL3 VAL D 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL3 VAL F 172 UNP U5T8W0 GLU 172 CONFLICT SEQADV 8EL3 VAL H 172 UNP U5T8W0 GLU 172 CONFLICT SEQRES 1 A 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 A 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 A 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 A 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 A 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 A 67 SER VAL SEQRES 1 B 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 B 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 B 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 B 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 B 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 B 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 B 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 B 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 B 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 B 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 B 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 B 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 B 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 B 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 C 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 C 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 C 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 C 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 C 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 D 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 D 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 D 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 D 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 D 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 D 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 D 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 D 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 D 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 D 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 D 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 D 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 D 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 D 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 E 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 E 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 E 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 E 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 E 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 F 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 F 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 F 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 F 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 F 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 F 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 F 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 F 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 F 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 F 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 F 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 F 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 F 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 F 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 G 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 G 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 G 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 G 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 G 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 G 67 SER VAL SEQRES 1 H 177 MET LEU ASP ALA PHE SER LYS VAL ILE THR SER ALA ASP SEQRES 2 H 177 GLY LYS ALA ALA TYR VAL GLY GLY ALA ASP LEU GLN ALA SEQRES 3 H 177 LEU LYS LYS PHE VAL SER GLU GLY ASN LYS ARG MET ASP SEQRES 4 H 177 SER VAL ASN ALA ILE VAL SER ASN ALA SER CYS ILE VAL SEQRES 5 H 177 SER ASP SER VAL SER GLY MET VAL CYS GLU ASN PRO SER SEQRES 6 H 177 LEU ILE ALA PRO ASN GLY GLY VAL TYR THR ASN ARG LYS SEQRES 7 H 177 MET ALA ALA CYS LEU ARG ASP ALA GLU ILE ILE LEU ARG SEQRES 8 H 177 TYR VAL SER TYR SER LEU LEU SER GLY ASP SER SER VAL SEQRES 9 H 177 LEU GLU ASP ARG CYS LEU ASN GLY LEU LYS GLU THR TYR SEQRES 10 H 177 ALA SER LEU GLY VAL PRO ALA ALA GLY ASN ALA ARG THR SEQRES 11 H 177 ILE SER ILE MET LYS ALA THR VAL ILE GLY PHE ILE THR SEQRES 12 H 177 ASN ASN SER GLN GLN LYS LYS LEU SER THR PRO ALA GLY SEQRES 13 H 177 ASP CYS SER ALA LEU ALA SER GLU VAL GLY GLY TYR PHE SEQRES 14 H 177 ASP LYS VAL SER SER ALA LEU ALA SEQRES 1 I 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 I 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 I 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 I 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 I 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU SEQRES 1 J 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 J 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 J 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 J 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 J 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 J 67 SER VAL SEQRES 1 K 67 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 K 67 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 K 67 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 K 67 MET LYS ALA ILE GLY PHE ASN ALA ALA GLU ALA ALA SER SEQRES 5 K 67 VAL THR LYS ASN TYR GLY ILE LYS ARG PHE GLY ALA LYS SEQRES 6 K 67 SER VAL SEQRES 1 L 62 ALA MET LYS LYZ ASP SER LYS ALA PRO CYS VAL GLU VAL SEQRES 2 L 62 PHE ASP GLU ARG ASP GLY CYS LYS ALA ALA GLY THR GLN SEQRES 3 L 62 LYS ALA SER GLY ASP ASP GLY PHE CYS VAL LYS VAL SER SEQRES 4 L 62 MET LYS ALA ILE LYS MET ASN ALA ALA GLU ALA THR SER SEQRES 5 L 62 VAL THR LYS ASN TYR ASN THR LYS LEU LEU MODRES 8EL3 LYZ A 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ C 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ E 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ G 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ I 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ J 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ K 4 LYS MODIFIED RESIDUE MODRES 8EL3 LYZ L 4 LYS MODIFIED RESIDUE HET LYZ A 4 21 HET LYZ C 4 21 HET LYZ E 4 21 HET LYZ G 4 21 HET LYZ I 4 21 HET LYZ J 4 21 HET LYZ K 4 21 HET LYZ L 4 21 HET PEB A 101 80 HET AX9 B 201 79 HET PEB B 202 80 HET PEB B 203 80 HET PEB C 101 80 HET AX9 D 201 79 HET PEB D 202 80 HET PEB D 203 80 HET PEB E 101 80 HET AX9 F 201 79 HET PEB F 202 80 HET PEB F 203 80 HET PEB G 101 80 HET AX9 H 201 79 HET PEB H 202 80 HET PEB H 203 80 HET PEB I 101 80 HET PEB J 101 80 HET PEB K 101 80 HET PEB L 101 80 HETNAM LYZ 5-HYDROXYLYSINE HETNAM PEB PHYCOERYTHROBILIN HETNAM AX9 DICYS-(15,16)-DIHYDROBILIVERDIN HETSYN AX9 15,16-DIHYDROBILIVERDIN (DOUBLE CYS BOUND FORM); 3- HETSYN 2 AX9 [(2Z)-2-({3-(2-CARBOXYETHYL)-5-[(Z)-(3-ETHYL-4-METHYL- HETSYN 3 AX9 5-OXO-1,5-DIHYDRO-2H-PYRROL-2-YLIDENE)METHYL]-4- HETSYN 4 AX9 METHYL-1H-PYRROL-2-YL}METHYLIDENE)-5-{[(2R)-4-ETHYL-3- HETSYN 5 AX9 METHYL-5-OXO-2,5-DIHYDRO-1H-PYRROL-2-YL]METHYL}-4- HETSYN 6 AX9 METHYL-2H-PYRROL-3-YL]PROPANOIC ACID FORMUL 1 LYZ 8(C6 H14 N2 O3) FORMUL 13 PEB 16(C33 H40 N4 O6) FORMUL 14 AX9 4(C33 H40 N4 O6) FORMUL 33 HOH *695(H2 O) HELIX 1 AA1 ASN A 46 TYR A 57 1 12 HELIX 2 AA2 PHE B 5 SER B 11 1 7 HELIX 3 AA3 GLY B 21 LYS B 28 1 8 HELIX 4 AA4 LYS B 29 VAL B 31 5 3 HELIX 5 AA5 GLU B 33 ASN B 47 1 15 HELIX 6 AA6 ASN B 47 ASN B 63 1 17 HELIX 7 AA7 PRO B 64 ALA B 68 5 5 HELIX 8 AA8 THR B 75 GLY B 100 1 26 HELIX 9 AA9 SER B 102 CYS B 109 1 8 HELIX 10 AB1 GLY B 112 GLY B 121 1 10 HELIX 11 AB2 PRO B 123 THR B 143 1 21 HELIX 12 AB3 CYS B 158 ALA B 177 1 20 HELIX 13 AB4 ASN C 46 TYR C 57 1 12 HELIX 14 AB5 SER D 6 SER D 11 1 6 HELIX 15 AB6 GLY D 21 LYS D 28 1 8 HELIX 16 AB7 GLU D 33 ASN D 47 1 15 HELIX 17 AB8 ASN D 47 ASN D 63 1 17 HELIX 18 AB9 PRO D 64 ALA D 68 5 5 HELIX 19 AC1 THR D 75 GLY D 100 1 26 HELIX 20 AC2 SER D 102 CYS D 109 1 8 HELIX 21 AC3 GLY D 112 GLY D 121 1 10 HELIX 22 AC4 PRO D 123 THR D 143 1 21 HELIX 23 AC5 CYS D 158 ALA D 177 1 20 HELIX 24 AC6 ASN E 46 TYR E 57 1 12 HELIX 25 AC7 SER F 6 SER F 11 1 6 HELIX 26 AC8 GLY F 21 VAL F 31 1 11 HELIX 27 AC9 GLU F 33 ASN F 47 1 15 HELIX 28 AD1 ASN F 47 ASN F 63 1 17 HELIX 29 AD2 PRO F 64 ALA F 68 5 5 HELIX 30 AD3 THR F 75 GLY F 100 1 26 HELIX 31 AD4 SER F 102 CYS F 109 1 8 HELIX 32 AD5 GLY F 112 GLY F 121 1 10 HELIX 33 AD6 PRO F 123 THR F 143 1 21 HELIX 34 AD7 CYS F 158 ALA F 177 1 20 HELIX 35 AD8 ASN G 46 TYR G 57 1 12 HELIX 36 AD9 SER H 6 SER H 11 1 6 HELIX 37 AE1 GLY H 21 PHE H 30 1 10 HELIX 38 AE2 GLU H 33 ASN H 47 1 15 HELIX 39 AE3 ASN H 47 ASN H 63 1 17 HELIX 40 AE4 PRO H 64 ALA H 68 5 5 HELIX 41 AE5 THR H 75 GLY H 100 1 26 HELIX 42 AE6 SER H 102 CYS H 109 1 8 HELIX 43 AE7 GLY H 112 GLY H 121 1 10 HELIX 44 AE8 PRO H 123 THR H 143 1 21 HELIX 45 AE9 CYS H 158 ALA H 177 1 20 HELIX 46 AF1 ASN I 46 TYR I 57 1 12 HELIX 47 AF2 ASN J 46 TYR J 57 1 12 HELIX 48 AF3 ASN K 46 TYR K 57 1 12 HELIX 49 AF4 ASN L 46 TYR L 57 1 12 SHEET 1 AA1 5 LYS A 7 ASP A 15 0 SHEET 2 AA1 5 PHE A 34 ALA A 42 -1 O SER A 39 N CYS A 10 SHEET 3 AA1 5 ALA B 17 GLY B 20 -1 O VAL B 19 N VAL A 36 SHEET 4 AA1 5 PHE I 34 ALA I 42 -1 N VAL I 36 O VAL B 19 SHEET 5 AA1 5 LYS I 7 ASP I 15 -1 N CYS I 10 O SER I 39 SHEET 1 AA2 5 LYS C 7 ASP C 15 0 SHEET 2 AA2 5 PHE C 34 ALA C 42 -1 O SER C 39 N CYS C 10 SHEET 3 AA2 5 ALA D 17 GLY D 20 -1 O VAL D 19 N VAL C 36 SHEET 4 AA2 5 PHE J 34 ALA J 42 -1 N VAL J 36 O VAL D 19 SHEET 5 AA2 5 LYS J 7 ASP J 15 -1 N CYS J 10 O SER J 39 SHEET 1 AA3 5 LYS E 7 ASP E 15 0 SHEET 2 AA3 5 PHE E 34 ALA E 42 -1 O SER E 39 N CYS E 10 SHEET 3 AA3 5 ALA F 17 GLY F 20 -1 O VAL F 19 N VAL E 36 SHEET 4 AA3 5 PHE K 34 ALA K 42 -1 N VAL K 36 O VAL F 19 SHEET 5 AA3 5 LYS K 7 ASP K 15 -1 N CYS K 10 O SER K 39 SHEET 1 AA4 5 LYS G 7 ASP G 15 0 SHEET 2 AA4 5 PHE G 34 ALA G 42 -1 O SER G 39 N CYS G 10 SHEET 3 AA4 5 ALA H 17 GLY H 20 -1 O VAL H 19 N VAL G 36 SHEET 4 AA4 5 PHE L 34 ALA L 42 -1 N VAL L 36 O VAL H 19 SHEET 5 AA4 5 LYS L 7 ASP L 15 -1 N CYS L 10 O SER L 39 LINK C ALYS A 3 N ALYZ A 4 1555 1555 1.33 LINK C ALYZ A 4 N AASP A 5 1555 1555 1.34 LINK SG ACYS A 20 CAAAPEB A 101 1555 1555 1.81 LINK SG CYS B 50 CBA AX9 B 201 1555 1555 1.75 LINK SG CYS B 61 CAD AX9 B 201 1555 1555 1.92 LINK SG CYS B 82 CAA PEB B 202 1555 1555 1.85 LINK SG CYS B 158 CAA PEB B 203 1555 1555 1.84 LINK C ALYS C 3 N ALYZ C 4 1555 1555 1.32 LINK C ALYZ C 4 N AASP C 5 1555 1555 1.33 LINK SG ACYS C 20 CAAAPEB C 101 1555 1555 1.81 LINK SG CYS D 50 CBA AX9 D 201 1555 1555 1.84 LINK SG CYS D 61 CAD AX9 D 201 1555 1555 1.86 LINK SG CYS D 82 CAA PEB D 202 1555 1555 1.82 LINK SG CYS D 158 CAA PEB D 203 1555 1555 1.83 LINK C ALYS E 3 N ALYZ E 4 1555 1555 1.33 LINK C ALYZ E 4 N AASP E 5 1555 1555 1.33 LINK SG ACYS E 20 CAAAPEB E 101 1555 1555 1.73 LINK SG CYS F 50 CBA AX9 F 201 1555 1555 1.79 LINK SG CYS F 61 CAD AX9 F 201 1555 1555 1.86 LINK SG CYS F 82 CAA PEB F 202 1555 1555 1.78 LINK SG CYS F 158 CAA PEB F 203 1555 1555 1.82 LINK C ALYS G 3 N ALYZ G 4 1555 1555 1.32 LINK C ALYZ G 4 N AASP G 5 1555 1555 1.33 LINK SG ACYS G 20 CAAAPEB G 101 1555 1555 1.81 LINK SG CYS H 50 CBA AX9 H 201 1555 1555 1.82 LINK SG CYS H 61 CAD AX9 H 201 1555 1555 1.86 LINK SG CYS H 82 CAA PEB H 202 1555 1555 1.85 LINK SG CYS H 158 CAA PEB H 203 1555 1555 1.84 LINK C BLYS I 3 N BLYZ I 4 1555 1555 1.33 LINK C BLYZ I 4 N BASP I 5 1555 1555 1.34 LINK SG BCYS I 20 CAABPEB I 101 1555 1555 1.81 LINK C BLYS J 3 N BLYZ J 4 1555 1555 1.32 LINK C BLYZ J 4 N BASP J 5 1555 1555 1.33 LINK SG BCYS J 20 CAABPEB J 101 1555 1555 1.81 LINK C BLYS K 3 N BLYZ K 4 1555 1555 1.33 LINK C BLYZ K 4 N BASP K 5 1555 1555 1.33 LINK SG BCYS K 20 CAABPEB K 101 1555 1555 1.73 LINK C BLYS L 3 N BLYZ L 4 1555 1555 1.32 LINK C BLYZ L 4 N BASP L 5 1555 1555 1.33 LINK SG BCYS L 20 CAABPEB L 101 1555 1555 1.81 CRYST1 64.802 76.840 103.360 90.00 110.73 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015432 0.000000 0.005841 0.00000 SCALE2 0.000000 0.013014 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010345 0.00000